ADRA2B Antibody (Center) Blocking Peptide

Catalog Number: ABT-BP8566C
Article Name: ADRA2B Antibody (Center) Blocking Peptide
Biozol Catalog Number: ABT-BP8566C
Supplier Catalog Number: BP8566c
Alternative Catalog Number: ABT-BP8566C-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Alpha-2B adrenergic receptor, Alpha-2 adrenergic receptor subtype C2, Alpha-2B adrenoreceptor, Alpha-2B adrenoceptor, Alpha-2BAR, ADRA2B, ADRA2L1, ADRA2RL1
Alpha-2-adrenergic receptors are members of the G protein-coupled receptor superfamily. They include 3 highly homologous subtypes: alpha2A, alpha2B, and alpha2C. These receptors have a critical role in regulating neurotransmitter release from sympathetic nerves and from adrenergic neurons in the central nervous system. Alpha 2B adrenergic receptor subtype was observed to associate with eIF-2B, a guanine nucleotide exchange protein that functions in regulation of translation. A polymorphic variant of the alpha2B subtype, which lacks 3 glutamic acids from a glutamic acid repeat element, was identified to have decreased G protein-coupled receptor kinase-mediated phosphorylation and desensitization, this polymorphic form is also associated with reduced basal metabolic rate in obese subjects and may therefore contribute to the pathogenesis of obesity. Alpha 2B adrenergic receptor gene contains no introns in either its coding or untranslated sequences.
NCBI: 151
UniProt: P18089
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8566c was selected from the Center region of human ADRA2B. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.